T regulatory cells, the evolution of targeted immunotherapy

被引:34
|
作者
Nizar, S. [1 ,2 ]
Meyer, B. [1 ]
Galustian, C. [1 ]
Kumar, D. [2 ]
Dalgleish, A. [1 ]
机构
[1] St Georges Univ London, Dept Cellular & Mol Med, London SW17 0RE, England
[2] St Georges Hosp NHS Trust, Dept Colorectal Surg, London, England
来源
关键词
T regulatory; Tregs; FOXP3; Cancer; Immunotherapy; PHASE-II TRIAL; DENILEUKIN DIFTITOX; DENDRITIC CELLS; ANTITUMOR IMMUNITY; CTLA-4; BLOCKADE; TGF-BETA; PERIPHERAL-BLOOD; PROSTATE-CANCER; FUSION PROTEIN; IN-VITRO;
D O I
10.1016/j.bbcan.2010.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T regulatory cells are able to suppress anti-tumour immunity in pre-clinical models and in patients. This review highlights the important discoveries in Treg immunology critical to the evolution of targeted immunotherapy. We also describe the therapeutic applications that are currently being assessed and their future potential. (C) 2010 Elsevier BM. All rights reserved.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 50 条
  • [21] Targeting regulatory T cells for immunotherapy in melanoma
    Huang, Lili
    Guo, Yeye
    Liu, Shujing
    Wang, Huaishan
    Zhu, Jinjin
    Ou, Lingling
    Xu, Xiaowei
    MOLECULAR BIOMEDICINE, 2021, 2 (01):
  • [22] Regulatory T cells:: magic bullets for immunotherapy?
    Frey, O
    Bräuer, R
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (01) : 33 - 43
  • [23] Regulatory T cells as potential immunotherapy in allergy
    Wing, Kajsa
    Sakaguchi, Shimon
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 6 (06) : 482 - 488
  • [24] Regulatory T cells, tumour immunity and immunotherapy
    Weiping Zou
    Nature Reviews Immunology, 2006, 6 : 295 - 307
  • [25] Targeting regulatory T cells for cancer immunotherapy
    Sakaguchi, Shimon
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [26] Are regulatory T cells the target of venom immunotherapy?
    Jutel, M
    Akdis, M
    Blaser, K
    Akdis, CA
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 5 (04) : 365 - 369
  • [27] Regulatory T cells, as a target in anticancer immunotherapy
    Enokida, Tomohiro
    Nishikawa, Hiroyoshi
    IMMUNOTHERAPY, 2017, 9 (08) : 623 - 627
  • [28] CD8+ T effector targeted elimination of regulatory tumor stroma cells for improved immunotherapy
    Shirwan, Haval
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 194 - 195
  • [29] Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
    Scheper, Wouter
    Grunder, Cordula
    Kuball, Jurgen
    ONCOIMMUNOLOGY, 2013, 2 (05)
  • [30] Regulatory T cells: A new frontier in cancer immunotherapy
    Barnett, Brian G.
    Rueter, Jens
    Kryczek, Ilona
    Brumlik, Michael J.
    Cheng, Pui Joan
    Daniel, Benjamin J.
    Coukos, George
    Zou, Weiping
    Curiel, Tyler J.
    OVARIAN CANCER: STATE OF THE ART AND FUTURE DIRECTIONS IN TRANSLATIONAL RESEARCH, 2008, 622 : 255 - 260